Scholar Rock Holding (SRRK) Other Non Operating Income (2017 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Other Non Operating Income of -$3.3 million for Q1 2026, down 7484.09% year-over-year from $45191.8 in Q1 2025, and down 5370.49% quarter-over-quarter from -$61000.0 in Q4 2025.
Powered by 
Analysis
Scholar Rock Holding (SRRK) Other Non Operating Income (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$3.3 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 7484.09% year-over-year to -$3.3 million; the TTM figure through Mar 2026 stood at -$3.6 million (down 3227.78% YoY), while the FY2025 annual figure was -$301000.0, down 254.12% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$3.3 million, down from -$61000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $21000.0 in Q1 2024, with the low at -$3.3 million in Q1 2026.
- The 3-year median for Other Non Operating Income is -$44000.0 (2025), against an average of -$409000.0.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income plunged 81.58% in 2025, then plunged 7484.09% in 2026.
- Scholar Rock Holding's Other Non Operating Income stood at -$12000.0 in 2024, then sank by 408.33% to -$61000.0 in 2025, then slumped by 5370.49% to -$3.3 million in 2026.
- Business Quant data shows SRRK's Other Non Operating Income at -$3.3 million in Q1 2026, -$61000.0 in Q4 2025, and -$69000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Scholar Rock Holding | 7.21 Bn | 7.21 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -570,000.00 |
| Mar 31, 2026 | -3.34 Mn |
| Dec 31, 2025 | -61,000.00 |
| Sep 30, 2025 | -69,000.00 |
| Jun 30, 2025 | -127,000.00 |
| Mar 31, 2025 | -44,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Jun 30, 2018 | -36,000.00 |
| Mar 31, 2018 | -20,000.00 |
| Dec 31, 2017 | -11,000.00 |
| Sep 30, 2017 | 4,000.00 |
| Jun 30, 2017 | -2,000.00 |